Shockwave Therapy for Traumatic Wounds and Burns of the Extremity (Army)
Abstract
To evaluate shockwave therapy to determine if it meets combat casualty care requirements for complex wound treatment. Non-healing wounds are a major medical problem, impairing the quality of life to soldiers with acute traumatic wounds. In order to access the feasibility and safety of shockwave therapy and determine if shockwave therapy significantly improves wound healing over current standards of care, we will conduct definitive field testing of the extracorporeal shock wave therapy device from Tissue Regeneration Technologies, Woodstock, Georgia. The primary outputs and efficiencies to be demonstrated in the field testing are: (1) accelerate tissue repair in wounds; (2) reduce infection-related amputations and deformity; (3) minimize number of surgical interventions; (4) reduce hospital time and cost; (5) facilitate early rehabilitation. The key benefit to the warfighter is a non-invasive, painless treatment method to reduce bacterial load in wounds and facilitate blood vessel in-growth and soft tissue healing. RDT&E cost avoidance of $3.300 million; estimated Return on Investment of $10.100 million.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2011
- Source ID
- 15815612df7fd62321132fcd7b8a5add